erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer.
Thor AD, Berry DA, Budman DR, Muss HB, Kute T, Henderson IC, Barcos M, Cirrincione C, Edgerton S, Allred C, Norton L, Liu ET.
Thor AD, et al. Among authors: berry da.
J Natl Cancer Inst. 1998 Sep 16;90(18):1346-60. doi: 10.1093/jnci/90.18.1346.
J Natl Cancer Inst. 1998.
PMID: 9747866
Clinical Trial.